1. Checkpoint inhibition-induced sicca: a type II interferonopathy?

   Pringle, S., Wang, X., Vissink, A., Bootsma, H. & Kroese, F. G. M., 12-Oct-2020, In : Clinical and Experimental Rheumatology.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. How ethnicity modifies systemic activity of primary Sjogren syndrome: analysis of baseline ESSDAI scores in a multi-ethnic international cohort

   Sjogren Big Data Consortium, 2018, In : Clinical and Experimental Rheumatology. 36, 3, p. S270-S270 1 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

3. Clinical and immunological disease patterns of primary Sjogren syndrome driven by gender and age at diagnosis

   Sjogren Big Data Consortium, 2018, In : Clinical and Experimental Rheumatology. 36, 3, p. S269-S270 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

4. How the different systemic organ involvements are overlapped in patients with primary Sjogren syndrome: analysis using a mathematical model

   Sjogren Big Data Consortium, 2018, In : Clinical and Experimental Rheumatology. 36, 3, p. S316-S317 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

5. Systemic Sjogren presenting without sicca syndrome: characterization of 240 patients according to the new 2017 ACR/EULAR Classification Criteria

   Sjogren Big Data Consortium, 2018, In : Clinical and Experimental Rheumatology. 36, 3, p. S268-S269 2 p.

   Research output: Contribution to journal › Meeting Abstract › Academic

View all (72) »